5AM Opportunities II (GP), LLC - 18 Dec 2025 SCHEDULE 13G Report for Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share (ZNTL)

Filing Manager
5AM Opportunities II (GP), LLC
Reporting Manager
Andrew J. Schwab
Security
Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share
Symbol
ZNTL
Shares outstanding
75,602,672 shares
Disclosed Ownership
4,838,571 shares
Ownership
6.4%
Form type
SCHEDULE 13G
Filing time
30 Dec 2025, 16:10:44 UTC
Date of event
18 Dec 2025
SEC
View on sec.gov

Reporting Managers (7)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
5AM Opportunities II (GP), LLC 5.2% 3,947,913 0 3,947,913 /s/ Andrew J. Schwab By Andrew J. Schwab, Managing Member
5AM Opportunities II, L.P. 5.2% 3,947,913 0 3,947,913 /s/ Andrew J. Schwab By 5AM Opportunities II (GP), LLC, its General Partner, By Andrew J. Schwab, Managing Member
5AM Opportunities (GP), LLC 1.2% 890,658 0 890,658 /s/ Andrew J. Schwab By Andrew J. Schwab, Managing Member
5AM Opportunities Master Fund L.P. 1.2% 890,658 0 890,658 /s/ Andrew J. Schwab By 5AM Opportunities II (GP), LLC, its General Partner, By Andrew J. Schwab, Managing Member
Andrew J. Schwab 6.4% 4,838,571 0 4,838,571 /s/ Andrew J. Schwab Andrew J. Schwab
Kush Parmar 6.4% 4,838,571 0 4,838,571 /s/ Kush Parmar Kush Parmar
Anna Yaeger 1.2% 890,658 0 890,658 /s/ Anna Yaeger Anna Yaeger